Collagen scaffolds incorporating select therapeutic agents to facilitate a reparative response in a standardized hemiresection defect in the rat spinal cord

Tissue Engineering - Part A

Volumn 18, Issue 19-20, 2012, Pages 2158-2172

  Cholas, Rahmatullah ^a,b   Hsu, Hu Ping ^b,c   Spector, Myron ^b,c  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELLS; DEFECTS; RATS;

ANGIOGENIC CELLS; AXON GROWTH; BIOMATERIAL SCAFFOLDS; COLLAGEN SCAFFOLDS; CONTROL GROUPS; DOSE-RESPONSE STUDY; HIND LIMBS; HOST CELLS; IN-CONTROL; MESENCHYMAL STEM CELL; MOTOR FUNCTION; NEUROTROPHIC FACTORS; RAT SPINAL CORD; REPARATIVE RESPONSE; SPINAL CORD INJURIES (SCI); THERAPEUTIC AGENTS; TYPE I COLLAGEN;

SCAFFOLDS (BIOLOGY);

ANIMALIA; RATTUS;

CHONDROITIN ABC LYASE; COLLAGEN; TISSUE SCAFFOLD;

ANIMAL; ARTICLE; CELL CULTURE; CHEMISTRY; CYTOLOGY; MALE; MESENCHYMAL STROMA CELL; METABOLISM; RAT; SPINAL CORD INJURY;

ANIMALS; CELLS, CULTURED; CHONDROITIN ABC LYASE; COLLAGEN; MALE; MESENCHYMAL STROMAL CELLS; RATS; SPINAL CORD INJURIES; TISSUE SCAFFOLDS;

EID: 84867003028     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0577     Document Type: Article

References (82)

1. Kerschensteiner, M., Schwab, M.E., Lichtman, J.W., and Misgeld, T. In vivo imaging of axonal degeneration and regeneration in the injured spinal cord. Nat Med 11, 572, 2005.
2. Hagg, T., and Oudega, M. Degenerative and spontaneous regenerative processes after spinal cord injury. J Neuro-trauma 23, 264, 2006.
3. Carmel, J.B., et al. Gene expression profiling of acute spinal cord injury reveals spreading inflammatory signals and neuron loss. Physiol Genomics 7, 201, 2001.
4. Woerly, S., Doan, V.D., Sosa, N., de Vellis, J., and Espinosa-Jeffrey, A. Prevention of gliotic scar formation by NeuroGel allows partial endogenous repair of transected cat spinal cord. J Neurosci Res 75, 262, 2004.
5. Suzuki, Y., et al. Electrophysiological and horseradish peroxidase-tracing studies of nerve regeneration through alginate-filled gap in adult rat spinal cord. Neurosci Lett 318, 121, 2002.
6. Yoshii, S., et al. Restoration of function after spinal cord transection using a collagen bridge. J Biomed Mater Res A 70, 569, 2004.
7. Nomura, H., et al. Delayed implantation of intramedullary chitosan channels containing nerve grafts promotes extensive axonal regeneration after spinal cord injury. Neuro-surgery 63, 127, 2008; discussion 141-123.
8. Vacanti, M.P., et al. Tissue-engineered spinal cord. Transplant Proc 33, 592, 2001.
9. Stokols, S., and Tuszynski, M.H. Freeze-dried agarose scaffolds with uniaxial channels stimulate and guide linear ax-onal growth following spinal cord injury. Biomaterials 27, 443, 2006.
10. Teng, Y.D., et al. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci U S A 99, 3024, 2002.
11. Chou, A.K., et al. Intrathecal gene delivery of glial cell line-derived neurotrophic factor ameliorated paraplegia in rats after spinal ischemia. Brain Res Mol Brain Res 133, 198, 2005.
12. Takahashi, K., et al. DNA plasmid that codes for human Bcl-2 gene preserves axotomized Clarke's nucleus neurons and reduces atrophy after spinal cord hemisection in adult rats. J Comp Neurol 404, 159, 1999.
13. Kuh, S.U., Cho, Y.E., Yoon, D.H., Kim, K.N., and Ha, Y. Functional recovery after human umbilical cord blood cells transplantation with brain-derived neutrophic factor into the spinal cord injured rat. Acta Neurochir (Wien) 147, 985, 2005.
14. Eftekharpour, E., Karimi-Abdolrezaee, S., and Fehlings, M.G. Current status of experimental cell replacement approaches to spinal cord injury. Neurosurg Focus 24, E19 2008.
15. Oudega, M., and Xu, X.M. Schwann cell transplantation for repair of the adult spinal cord. J Neurotrauma 23, 453, 2006.
16. Lopez-Vales, R., Fores, J., Verdu, E., and Navarro, X. Acute and delayed transplantation of olfactory ensheathing cells promote partial recovery after complete transection of the spinal cord. Neurobiol Dis 21, 57, 2006.
17. Ramon-Cueto, A., Plant, G.W., Avila, J., and Bunge, M.B. Long-distance axonal regeneration in the transected adult rat spinal cord is promoted by olfactory ensheathing glia transplants. J Neurosci 18, 3803, 1998.
18. Franzen, R., Martin, D., Daloze, A., Moonen, G., and Schoenen, J. Grafts of meningeal fibroblasts in adult rat spinal cord lesion promote axonal regrowth. Neuroreport 10, 1551, 1999.
19. Ramer, L.M., et al. Peripheral olfactory ensheathing cells reduce scar and cavity formation and promote regeneration after spinal cord injury. J Comp Neurol 473, 1, 2004.
20. Weinreb, P.H., et al. Resolution of disulfide heterogeneity in Nogo receptor I fusion proteins by molecular engineering. Biotechnol appl biochem 57, 31, 2010.
21. Bradbury, E.J., et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416, 636, 2002.
22. Marchand, R., and Woerly, S. Transected spinal cords grafted with insitu self-assembled collagen matrices. Neuroscience 36, 45, 1990.
23. Gelderd, J.B. Evaluation of blood vessel and neurite growth into a collagen matrix placed within a surgically created gap in rat spinal cord. Brain res 511, 80, 1990.
24. Joosten, E.A., Bar, P.R., and Gispen, W.H. Collagen implants and cortico-spinal axonal growth after mid-thoracic spinal cord lesion in the adult rat. J neurosci res 41, 481, 1995.
25. Spilker, M.H., et al. The effects of collagen-based implants on early healing of the adult rat spinal cord. Tissue Eng 3, 309, 1997.
26. Spilker, M.H., et al. The effects of tubulation on healing and scar formation after transection of the adult rat spinal cord. Restor Neurol Neurosci 18, 23, 2001.
27. Ma, W., et al. Reconstruction of functional cortical-like tissues from neural stem and progenitor cells. Tissue Eng Part A 14, 1673, 2008.
28. Watanabe, K., Nakamura, M., Okano, H., and Toyama, Y. Establishment of three-dimensional culture of neural stem/progenitor cells in collagen Type-1 Gel. Restor Neurol Neurosci 25, 109, 2007.
29. Willits, R.K., and Skornia, S.L. Effect of collagen gel stiffness on neurite extension. J biomaterials sci 15, 1521, 2004.
30. Eccleston, P., Mirsky, R., and Jessen, K. Type I collagen preparations inhibit DNA synthesis in glial cells of the peripheral nervous system. Exp Cell Res 182, 173, 1989.
31. Li, W., et al. A neutralizing anti-Nogo66 receptor monoclonal antibody reverses inhibition of neurite outgrowth by central nervous system myelin. J Biol Chem 279, 43780, 2004.
32. Lee, D.H., Strittmatter, S.M., and Sah, D.W. Targeting the Nogo receptor to treat central nervous system injuries. Nat Rev Drug Discov 2, 872, 2003.
33. Li, S., et al. Blockade of Nogo-66, myelin-associated glyco-protein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury. J Neurosci 24, 10511, 2004.
34. Liebscher, T., et al. Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats. Ann Neurol 58, 706, 2005.
35. Ji, B., et al. Effect of combined treatment with methylpred-nisolone and soluble Nogo-66 receptor after rat spinal cord injury. Eur J Neurosci 22, 587, 2005.
36. Harvey, P.A., Lee, D.H., Qian, F., Weinreb, P.H., and Frank, E. Blockade of Nogo receptor ligands promotes functional regeneration of sensory axons after dorsal root crush. J Neurosci 29, 6285, 2009.
37. Chau, C.H., et al. Chondroitinase ABC enhances axonal re-growth through Schwann cell-seeded guidance channels after spinal cord injury. Faseb J 18, 194, 2004.
38. Cummings, B.J., et al. Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc Natl Acad Sci U S A 102, 14069, 2005.
39. Lu, P., Jones, L.L., Snyder, E.Y., and Tuszynski, M.H. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 181, 115, 2003.
40. Salazar, D.L., Uchida, N., Hamers, F.P.T., Cummings, B.J., and Anderson, A.J. Human neural stem cells differentiate and promote locomotor recovery in an early chronic spinal cord injury NOD-scid mouse model. PLoS One 5, e12272, 2010.
41. Cao, Q., et al. Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells. J Neurosci 25, 6947, 2005.
42. Ruitenberg, M.J., et al. NT-3 expression from engineered olfactory ensheathing glia promotes spinal sparing and regeneration. Brain 128, 839, 2005.
43. Rooney, G.E., et al. Neurotrophic factor-expressing mesen-chymal stem cells survive transplantation into the contused spinal cord without differentiating into neural cells. Tissue Eng Part A 15, 3049, 2009.
44. Blesch, A., and Tuszynski, M.H. Cellular GDNF delivery promotes growth of motor and dorsal column sensory axons after partial and complete spinal cord transections and induces remyelination. J Comp Neurol 467, 403, 2003.
45. Fukunaga, S., et al. Experimental study of neural repair of the transected spinal cord using peripheral nerve graft. J Orthop Sci 9, 605, 2004.
46. Madaghiele, M., Sannino, A., Yannas, I.V., and Spector, M. Collagen-based matrices with axially oriented pores. J Biomed Mater Res A 85, 757, 2008.
47. Chamberlain, L.J., and Yannas, I.V. Preparation of collagen- glycosaminoglycan copolymers for tissue regeneration. In: Morgan. J., and Yarmush, M., eds. Tissue Engineering Methods and Protocols. Vol. 18, Totowa, NJ: Humana Press Inc.: 1999, pp. 3-17.
48. Cholas, R.H. Collagen scaffolds in full-and hemi-resection spinal cord injury models [Ph.D. thesis]. Massachusetts Institute of Technology, Cambridge, MA, 2011.
49. Lee, C.R., Grodzinsky, A.J., and Spector, M. The effects of cross-linking of collagen-glycosaminoglycan scaffolds on compressive stiffness, chondrocyte-mediated contraction, proliferation and biosynthesis. Biomaterials 22, 3145, 2001.
50. Harley, B.A., et al. Optimal degradation rate for collagen chambers used for regeneration of peripheral nerves over long gaps. Cells Tissues Organs 176, 153, 2004.
51. Olde Damink, L.H., et al. Cross-linking of dermal sheep collagen using a water-soluble carbodiimide. Biomaterials 17, 765, 1996.
52. Tsutsumi, S., et al. Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun 288, 413, 2001.
53. Mastrogiacomo, M., Cancedda, R., and Quarto, R. Effect of different growth factors on the chondrogenic potential of human bone marrow stromal cells. Osteoarthritis Cartilage 9 Suppl A, S36, 2001.
54. Solchaga, L.A., et al. FGF-2 enhances the mitotic and chon-drogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol 203, 398, 2005.
55. Neubauer, M., et al. Adipose tissue engineering based on mesenchymal stem cells and basic fibroblast growth factor in vitro. Tissue Eng 11, 1840, 2005.
56. Quarto, N., and Longaker, M.T. FGF-2 inhibits osteogenesis in mouse adipose tissue-derived stromal cells and sustains their proliferative and osteogenic potential state. Tissue Eng 12, 1405, 2006.
57. Tropel, P., et al. Functional neuronal differentiation of bone marrow-derived mesenchymal stem cells. Stem Cells 24, 2868, 2006.
58. Cai, J., Ziemba, K.S., Smith, G.M., and Jin, Y. Evaluation of cellular organization and axonal regeneration through linear PLA foam implants in acute and chronic spinal cord injury. J Biomed Mater Res A 83, 512, 2007.
59. De Laporte, L., Lei Yan, A., and Shea, L.D. Local gene delivery from ECM-coated poly(lactide-co-glycolide) multiple channel bridges after spinal cord injury. Biomaterials 30, 2361, 2009.
60. De Laporte, L., et al. Plasmid releasing multiple channel bridges for transgene expression after spinal cord injury. Mol Ther 17, 318, 2009.
61. Wrathall, J.R., Pettegrew, R.K., and Harvey, F. Spinal cord contusion in the rat: production of graded, reproducible, injury groups. Exp Neurol 88, 108, 1985.
62. Tarlov, I.M., and Klinger, H. Spinal cord compression studies. II. Time limits for recovery after acute compression in dogs. AMA Arch Neurol Psychiatry 71, 271, 1954.
63. Basso, D.M., Beattie, M.S., and Bresnahan, J.C. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12, 1, 1995.
64. Casella, G.T., Marcillo, A., Bunge, M.B., and Wood, P.M. New vascular tissue rapidly replaces neural parenchyma and vessels destroyed by a contusion injury to the rat spinal cord. Exp Neurol 173, 63, 2002.
65. Loy, D.N., et al. Temporal progression of angiogenesis and basal lamina deposition after contusive spinal cord injury in the adult rat. J Comp Neurol 445, 308, 2002.
66. Leibovich, S.J., et al. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 329, 630, 1987.
67. Bartholdi, D., Rubin, B.P., and Schwab, M.E. VEGF mRNA induction correlates with changes in the vascular architecture upon spinal cord damage in the rat. Eur J Neurosci 9, 2549, 1997.
68. Buss, A., et al. Sequential loss of myelin proteins during Wallerian degeneration in the human spinal cord. Brain 128, 356, 2005.
69. Popovich, P.G., Wei, P., and Stokes, B.T. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J Comp Neurol 377, 443-464, 1997. (Pubitemid 27016650)
70. Keane, R.W., Davis, A.R., and Dietrich, W.D. Inflammatory and apoptotic signaling after spinal cord injury. J Neuro-trauma 23, 335, 2006.
71. Donnelly, D.J. and Popovich, P.G. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol 209, 378, 2008.
72. Fitch, M.T., Doller, C., Combs, C.K., Landreth, G.E., and Silver, J. Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J Neurosci 19, 8182, 1999.
73. Kostyk, S.K., Popovich, P.G., Stokes, B.T., Wei, P., and Jakeman, L.B. Robust axonal growth and a blunted macrophage response are associated with impaired functional recovery after spinal cord injury in the MRL/MpJ mouse. Neuroscience 156, 498, 2008.
74. Zukor, K., and He, Z. Regenerative medicine: drawing breath after spinal injury. Nature 475, 177, 2011.
75. Yin, Y., et al. Macrophage-derived factors stimulate optic nerve regeneration. J Neurosci 23, 2284, 2003.
76. Schwartz, M., and Yoles, E. Immune-based therapy for spinal cord repair: autologous macrophages and beyond. J Neurotrauma 23, 360, 2006.
77. Buffo, A., Rolando, C., and Ceruti, S. Astrocytes in the damaged brain: molecular and cellular insights into their reactive response and healing potential. Biochem Pharmacol 79, 77, 2010.
78. Faulkner, J.R., et al. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci 24, 2143, 2004.
79. Rolls, A., Shechter, R., and Schwartz, M. The bright side of the glial scar in CNS repair. Nat Rev Neurosci 10, 235, 2009.
80. Firkins, S.S., Bates, C.A., and Stelzner, D.J. Corticospinal tract plasticity and astroglial reactivity after cervical spinal injury in the postnatal rat. Exp Neurol 120, 1, 1993.
81. Gilbert, R.J., et al. CS-4, 6 is differentially upregulated in glial scar and is a potent inhibitor of neurite extension. Mol Cell Neurosci 29, 545, 2005.
82. McGrath, M.H., and Hundahl, S. The spatial and temporal quantification of myofibroblasts. Plast Reconstr Surg 69, 975, 1982.